Molecular Characterization and Patient Outcome of Melanoma Nodal Metastases and an Unknown Primary Site

作者: Aleksandra Gos , Monika Jurkowska , Alexander van Akkooi , Caroline Robert , Hanna Kosela-Paterczyk

DOI: 10.1245/S10434-014-3799-Y

关键词: MedicineInternal medicineNODALSurgical oncologyMelanomaClinical manifestationPathologyUnknown primaryOncologyNeuroblastoma RAS viral oncogene homolog

摘要: Background Melanoma of unknown primary site (MUP) is not a completely understood entity with nodal metastases as the most common first clinical manifestation. The aim this multicentric study was to assess frequency and type oncogenic BRAF/NRAS/KIT mutations in MUP clinically detected relation clinicopathologic features outcome.

参考文章(42)
Kevin K. Anbari, Lynn M. Schuchter, Louis P. Bucky, Rosemarie Mick, Marie Synnestvedt, DuPont Guerry, Ralph Hamilton, Allan C. Halpern, , Melanoma of unknown primary site : Presentation, treatment, and prognosis : A single institution study Cancer. ,vol. 79, pp. 1816- 1821 ,(1997) , 10.1002/(SICI)1097-0142(19970501)79:9<1816::AID-CNCR26>3.0.CO;2-#
Ken Dutton-Regester, Hojabr Kakavand, Lauren G. Aoude, Mitchell S. Stark, Michael G. Gartside, Peter Johansson, Linda O'Connor, Cathy Lanagan, Varsha Tembe, Gulietta M. Pupo, Lauren E. Haydu, Christopher W. Schmidt, Graham J. Mann, John F. Thompson, Richard A. Scolyer, Nicholas K. Hayward, Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanoma Pigment Cell & Melanoma Research. ,vol. 26, pp. 852- 860 ,(2013) , 10.1111/PCMR.12153
John A. Curtin, Jane Fridlyand, Toshiro Kageshita, Hetal N. Patel, Klaus J. Busam, Heinz Kutzner, Kwang-Hyun Cho, Setsuya Aiba, Eva-Bettina Bröcker, Philip E. LeBoit, Dan Pinkel, Boris C. Bastian, Distinct Sets of Genetic Alterations in Melanoma The New England Journal of Medicine. ,vol. 353, pp. 2135- 2147 ,(2005) , 10.1056/NEJMOA050092
Esther Edlundh-Rose, Suzanne Egyha??zi, Katarina Omholt, Eva Mansson-Brahme, Anton Platz, Johan Hansson, Joakim Lundeberg, NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing Melanoma Research. ,vol. 16, pp. 471- 478 ,(2006) , 10.1097/01.CMR.0000232300.22032.86
K. Kamposioras, G. Pentheroudakis, D. Pectasides, N. Pavlidis, Malignant melanoma of unknown primary site. To make the long story short. A systematic review of the literature. Critical Reviews in Oncology Hematology. ,vol. 78, pp. 112- 126 ,(2011) , 10.1016/J.CRITREVONC.2010.04.007
Claudia Wellbrock, Adam Hurlstone, BRAF as therapeutic target in melanoma Biochemical Pharmacology. ,vol. 80, pp. 561- 567 ,(2010) , 10.1016/J.BCP.2010.03.019
Kenneth A. Katz, Eric Jonasch, F. Stephen Hodi, Robert Soiffer, Kimberly Kwitkiwski, Arthur J. Sober, Frank G. Haluska, Melanoma of unknown primary: experience at Massachusetts General Hospital and Dana-Farber Cancer Institute Melanoma Research. ,vol. 15, pp. 77- 82 ,(2005) , 10.1097/00008390-200502000-00013
Wesley O Greaves, Shalini Verma, Keyur P Patel, Michael A Davies, Bedia A Barkoh, John M Galbincea, Hui Yao, Alexander J Lazar, Kenneth D Aldape, L Jeffrey Medeiros, Rajyalakshmi Luthra, None, Frequency and Spectrum of BRAF Mutations in a Retrospective, Single-Institution Study of 1112 Cases of Melanoma The Journal of Molecular Diagnostics. ,vol. 15, pp. 220- 226 ,(2013) , 10.1016/J.JMOLDX.2012.10.002
PIOTR RUTKOWSKI, ZBIGNIEW I. NOWECKI, WIRGINIUSZ DZIEWIRSKI, MARCIN ZDZIENICKI, ANDRZEJ PIEÑKOWSKI, MACIEJ SALAMACHA, WANDA MICHEJ, SLAWOMIR TREPKA, ELZBIETA BYLINA, WLODZIMIERZ RUKA, Melanoma without a detectable primary site with metastases to lymph nodes Dermatologic Surgery. ,vol. 36, pp. 868- 876 ,(2010) , 10.1111/J.1524-4725.2010.01562.X
Janice N. Cormier, Yan Xing, Lei Feng, Xuelin Huang, Latunya Davidson, Jeffrey E. Gershenwald, Jeffrey E. Lee, Paul F. Mansfield, Merrick I. Ross, Metastatic melanoma to lymph nodes in patients with unknown primary sites Cancer. ,vol. 106, pp. 2012- 2020 ,(2006) , 10.1002/CNCR.21835